Clinical Trial

Feasibility of Intraoperative Tracing of Meningioma Using [Cu64]DOTATATE

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The study team hypothesizes that it is feasible to intraoperatively detect tumor following \[CU64\]DOTATATE injection using the gamma probe device.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2024-04-18; most recent amendment 2026-02-24.
Status change: Not Yet Recruiting → Recruiting 2024-10-29
Trial Details
NCT Number NCT06377371
Lead Sponsor Weill Medical College of Cornell University
Collaborators: Curium US LLC
Conditions Meningioma
Enrollment 20 participants
Start Date 2024-09-11
Primary Completion 2027-01 (estimated)
Study Completion 2027-01 (estimated)
Updated on ClinicalTrials.gov 2026-02-27